Nakashima H - Search Results

1

The features and shortcomings for gene delivery of current non-viral carriers.

Kodama K, Katayama Y, Shoji Y, Nakashima H. Kodama K, et al. Among authors: nakashima h. Curr Med Chem. 2006;13(18):2155-61. doi: 10.2174/092986706777935276. Curr Med Chem. 2006. PMID: 16918345 Review.

2

Current status of delivery systems to improve target efficacy of oligonucleotides.

Shoji Y, Nakashima H. Shoji Y, et al. Among authors: nakashima h. Curr Pharm Des. 2004;10(7):785-96. doi: 10.2174/1381612043453009. Curr Pharm Des. 2004. PMID: 15032703 Review.

3

Glucose-lowering effect of powder formulation of African black tea extract in KK-A(y)/TaJcl diabetic mouse.

Shoji Y, Nakashima H. Shoji Y, et al. Among authors: nakashima h. Arch Pharm Res. 2006 Sep;29(9):786-94. doi: 10.1007/BF02974080. Arch Pharm Res. 2006. PMID: 17024853

4

Drug delivery system based on responses to an HIV infectious signal.

Asai D, Kodama KB, Shoji Y, Nakashima H, Kawamura K, Oishi J, Kuramoto M, Niidome T, Katayama Y. Asai D, et al. Among authors: nakashima h. Med Chem. 2008 Jul;4(4):386-91. doi: 10.2174/157340608784872307. Med Chem. 2008. PMID: 18673152

5

Inflammatory cell-specific transgene expression system responding to Ikappa-B kinase beta activation.

Asai D, Tsuchiya A, Kang JH, Kawamura K, Oishi J, Mori T, Niidome T, Shoji Y, Nakashima H, Katayama Y. Asai D, et al. Among authors: nakashima h. J Gene Med. 2009 Jul;11(7):624-32. doi: 10.1002/jgm.1342. J Gene Med. 2009. PMID: 19424988

6

Specific transgene expression in HIV-infected cells using protease-cleavable transcription regulator.

Asai D, Kuramoto M, Shoji Y, Kang JH, Kodama KB, Kawamura K, Mori T, Miyoshi H, Niidome T, Nakashima H, Katayama Y. Asai D, et al. Among authors: nakashima h. J Control Release. 2010 Jan 4;141(1):52-61. doi: 10.1016/j.jconrel.2009.08.025. Epub 2009 Sep 4. J Control Release. 2010. PMID: 19733602

7

Nutraceutics and delivery systems.

Shoji Y, Nakashima H. Shoji Y, et al. Among authors: nakashima h. J Drug Target. 2004 Jul;12(6):385-91. doi: 10.1080/10611860400003817. J Drug Target. 2004. PMID: 15545088 Review.

8

Design of polymeric carriers for cancer-specific gene targeting: utilization of abnormal protein kinase Calpha activation in cancer cells.

Kang JH, Asai D, Kim JH, Mori T, Toita R, Tomiyama T, Asami Y, Oishi J, Sato YT, Niidome T, Jun B, Nakashima H, Katayama Y. Kang JH, et al. Among authors: nakashima h. J Am Chem Soc. 2008 Nov 12;130(45):14906-7. doi: 10.1021/ja805364s. Epub 2008 Oct 18. J Am Chem Soc. 2008. PMID: 18928283

9

Direct, real-time, simultaneous monitoring of intravitreal nitric oxide and oxygen in endotoxin-induced uveitis in rabbits.

Yomura Y, Shoji Y, Asai D, Murakami E, Ueno S, Nakashima H. Yomura Y, et al. Among authors: nakashima h. Life Sci. 2007 Mar 27;80(16):1449-57. doi: 10.1016/j.lfs.2007.01.021. Epub 2007 Jan 20. Life Sci. 2007. PMID: 17303180

10

Peptide substrates for G protein-coupled receptor kinase 2.

Asai D, Toita R, Murata M, Katayama Y, Nakashima H, Kang JH. Asai D, et al. Among authors: nakashima h. FEBS Lett. 2014 Jun 13;588(13):2129-32. doi: 10.1016/j.febslet.2014.04.038. Epub 2014 May 9. FEBS Lett. 2014. PMID: 24813628 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,879 results

Search Page